PROCEEDINGS VOLUME 1645
OE/LASE '92 | 19-24 JANUARY 1992
Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy
OE/LASE '92
19-24 January 1992
Los Angeles, CA, United States
New Applications of Photodynamic Therapy
Proc. SPIE 1645, Feasibility of intrapleural photodynamic therapy: the first eight patients (Invited Paper), 0000 (1 June 1992); doi: 10.1117/12.60923
Proc. SPIE 1645, Photodynamic therapy for treatment of AIDS-related mucocutaneous Kaposi's sarcoma (Invited Paper), 0000 (1 June 1992); doi: 10.1117/12.60924
Proc. SPIE 1645, Whole bladder wall photodynamic therapy with in-situ light dosimetry for carcinoma in situ of the bladder, 0000 (1 June 1992); doi: 10.1117/12.60925
Proc. SPIE 1645, Individual in-vitro sensitivities of human pancreatic carcinoma cell lines to photodynamic therapy, 0000 (1 June 1992); doi: 10.1117/12.60926
Proc. SPIE 1645, Clinical, MRI, and histological results after photodynamic therapy of oral cancer, 0000 (1 June 1992); doi: 10.1117/12.60927
Proc. SPIE 1645, Photodynamic therapy on spontaneous tumors of dogs and cats: a ten-year study, 0000 (1 June 1992); doi: 10.1117/12.60928
Proc. SPIE 1645, Hematopoietic stimulation by porphyrin photosensitizers (Invited Paper), 0000 (1 June 1992); doi: 10.1117/12.60929
Tissue Effects in PDT
Proc. SPIE 1645, Promotion of porphyrin cytotoxicity by ultrasound (Invited Paper), 0000 (1 June 1992); doi: 10.1117/12.60930
Proc. SPIE 1645, Photodynamic therapy responsiveness using mono-1-aspartyl chlorin e6 (Invited Paper), 0000 (1 June 1992); doi: 10.1117/12.60931
Proc. SPIE 1645, Mechanisms of vessel damage in photodynamic therapy (Invited Paper), 0000 (1 June 1992); doi: 10.1117/12.60932
Proc. SPIE 1645, Analysis of photochemical oxygen consumption effects in photodynamic therapy (Invited Paper), 0000 (1 June 1992); doi: 10.1117/12.60933
Proc. SPIE 1645, Role of multidrug resistance in photodynamic therapy, 0000 (1 June 1992); doi: 10.1117/12.60934
Proc. SPIE 1645, Host cell infiltration into PDT-treated tumor, 0000 (1 June 1992); doi: 10.1117/12.60935
Proc. SPIE 1645, Influence of metronidazole and some electron acceptors on the chlorin e6 photosensitized killing of Ehrlich carcinoma cells, 0000 (1 June 1992); doi: 10.1117/12.60936
Dosimetry/Instrumentation for PDT
Proc. SPIE 1645, Polymer-bound meso-chlorin e6 for PDT (Invited Paper), 0000 (1 June 1992); doi: 10.1117/12.60937
Proc. SPIE 1645, Simple optical theory for light dosimetry during PDT (Invited Paper), 0000 (1 June 1992); doi: 10.1117/12.60938
Proc. SPIE 1645, Optical methods for in-vivo pharmacokinetics (Invited Paper), 0000 (1 June 1992); doi: 10.1117/12.60939
Proc. SPIE 1645, Laser-induced fluorescence quantitation of choloroaluminum phthalocyanine tetrasulfonate concentration in rat tissue, 0000 (1 June 1992); doi: 10.1117/12.60940
Proc. SPIE 1645, Photodynamic therapy in interplay with fluorescence diagnostics in the treatment of human superficial malignancies, 0000 (1 June 1992); doi: 10.1117/12.60941
Proc. SPIE 1645, Spherical diffusing probes for high-peak-power copper vapor/dye laser systems, 0000 (1 June 1992); doi: 10.1117/12.60942
Proc. SPIE 1645, Effectiveness of photosensitive dye during uptake and redistribution, 0000 (1 June 1992); doi: 10.1117/12.60943
Proc. SPIE 1645, Diffuse reflection measurements determining optical properties of tissues, 0000 (1 June 1992); doi: 10.1117/12.60944
Potential New Photosenitizers for PDT
Proc. SPIE 1645, Photodynamic effects of silicon phthalocyanines in model cells and tumors (Invited Paper), 0000 (1 June 1992); doi: 10.1117/12.60945
Proc. SPIE 1645, Three new phthalocyanines with potential for PDT studies, 0000 (1 June 1992); doi: 10.1117/12.60946
Proc. SPIE 1645, Spectroscopy, photokinetics, and cellular effect of far-red and near-infrared absorbing photosensitizers, 0000 (1 June 1992); doi: 10.1117/12.60947
Proc. SPIE 1645, Improved photosensitizers for photodynamic therapy, 0000 (1 June 1992); doi: 10.1117/12.60948
Proc. SPIE 1645, Syntheses of new porphyrin-type photosensitizers for photodynamic therapy, 0000 (1 June 1992); doi: 10.1117/12.60949
Proc. SPIE 1645, Spectroscopic investigation of light-induced intracellular reactions of hydrophilic meso-tetraphenylporphyrins, 0000 (1 June 1992); doi: 10.1117/12.60950
Dosimetry/Instrumentation for PDT
Proc. SPIE 1645, Dosimetry of cylindrical fibers in photodynamic therapy, 0000 (1 June 1992); doi: 10.1117/12.60951
Proc. SPIE 1645, Clinical LIF pharmacokinetic measurements with Photofrin II for optimizing the photodetection of early cancer, 0000 (1 June 1992); doi: 10.1117/12.60952
Back to Top